ARCH Venture Partners is one of very few billion-dollar venture firms that focuses almost exclusively on founding and building companies directly out of universities and research institutions at the "concept" stage, positioning itself as a "company builder" that co-founds companies with scientists rather than waiting for spinouts to be formed. The firm concentrates its capital on breakthrough life sciences and deep science platforms with a stated mission to "catalyze discoveries that prevent, detect, and cure disease," serving as the partner of choice for world-class scientists who want to commercialize frontier biology.